Insights

Rapid innovation in the MedTech sector has original equipment manufacturers seeking CDMO partners that can provide operational efficiencies, specialized expertise, and enhanced quality to support device development and commercialization. Marwood reviews the core services and regulatory considerations that are driving changes in the sector.

When it comes to mitigating compliance risk and audits, providers may actually draw greater risk to themselves by undercoding. Herein, Marwood reviews the risks of performing fraud and abuse by undercoding, the financial impact that it has on healthcare organizations, and actionable steps to mitigate future risk.

“White bagging” is increasingly being utilized by insurers to control provider-administered drug spend. Herein, Marwood presents payor strategies and patient/provider pushback to its implementation.

Marwood explores the trends and interactions shaping independent, hospital and physician office diagnostic laboratories in the face of reimbursement and consolidation pressures.

The COVID-19 pandemic has brought virtual clinical trial enablement into focus. A spectrum of technologies transformative to traditional trial management, we present areas of growth in a broadening clinical research vendor landscape flush with investor activity that is rapidly being shaped by regulatory and legislative activity.

In order for strong financial recovery to occur, it needs to begin now, even as we are still in the midst of the pandemic. Hospitals cannot rely solely on governmental intervention. As both the duration of the pandemic and what life after it will look like are still unclear, it’s even more important to initiate programs to accelerate cash, reduce costs, and reduce debt. In this white paper, Marwood explores strategies that will enable hospitals emerging from the clutches of the pandemic to not only recover quickly, but also thrive.

Millions of Americans have lost their jobs as a result of COVID-19, often losing their health insurance simultaneously. When individuals lose their employer-based minimum essential coverage, they qualify for a special enrollment period (SEP), and can enroll in individual market plans through the ACA exchanges. In this white paper, Marwood Group explores the impact of the dramatic increase in unemployment on exchange plan enrollment, with a particular focus on state-run exchanges that have established SEPs in response to the pandemic-driven economic downturn.